These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4074610)

  • 1. Contrasts between pindolol and propranolol concentration-response relationships.
    Carruthers SG; Pacha WL; Aellig WH
    Br J Clin Pharmacol; 1985 Oct; 20(4):417-20. PubMed ID: 4074610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observations on three dosage forms of pindolol.
    Carruthers SG
    Am Heart J; 1982 Aug; 104(2 Pt 2):451-5. PubMed ID: 7102531
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the effect of pindolol and propranolol on heart rate after acute and chronic administration.
    Finch MB; O'Connor PC; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1983 Apr; 15(4):431-4. PubMed ID: 6849778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.
    O'Connor PC; Finch MJ; Harron DW; Meredith PA; McDevitt DG; Shanks RG
    Br J Clin Pharmacol; 1985 Dec; 20(6):659-67. PubMed ID: 2868744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers.
    Aellig WH
    Br J Clin Pharmacol; 1976 Apr; 3(2):251-7. PubMed ID: 973959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
    Tomlinson B; Cronin CJ; Graham BR; Prichard BN
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S69-75. PubMed ID: 2454372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experiments with pindolol (Visken) in healthy volunteers.
    Aellig WH
    Med J Aust; 1977 Sep; 2(SP2):8-11. PubMed ID: 927284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The distribution of propranolol, pindolol and atenolol between human erythrocytes and plasma.
    Taylor EA; Turner P
    Br J Clin Pharmacol; 1981 Oct; 12(4):543-8. PubMed ID: 7295488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose- and time-dependent binding and kinetics of pindolol in patients with congestive heart failure.
    Lima JJ; Binkley PF; Johnson J; Leier CV
    J Clin Pharmacol; 1986 Apr; 26(4):253-7. PubMed ID: 3700683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between oral verapamil and beta-blockers during submaximal exercise: relevance of ancillary properties.
    Bailey DG; Carruthers SG
    Clin Pharmacol Ther; 1991 Apr; 49(4):370-6. PubMed ID: 2015727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single and multiple dose pharmacokinetics of pindolol.
    Gugler R; Bodem G
    Eur J Clin Pharmacol; 1978 Mar; 13(1):13-6. PubMed ID: 639828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosing rate-dependent relationship between propranolol plasma concentration and beta-blockade.
    Takahashi H; Ogata H; Kashiwada K; Ohira M; Someya K
    J Pharmacol Exp Ther; 1993 May; 265(2):681-9. PubMed ID: 8496815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure reactivity in the evaluation of resting blood pressure and mood responses to pindolol and propranolol in hypertensive patients.
    Potempa KM; Fogg LF; Fish AF; Kravitz HM
    Heart Lung; 1993; 22(5):383-91. PubMed ID: 8226001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentration-response relationships of two formulations of propranolol.
    DeLeve LD; Endrenyi L; Leenen FH
    J Clin Pharmacol; 1985 Apr; 25(3):182-6. PubMed ID: 3998198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stereoselective determination of racemic pindolol in rat plasma and its application].
    Hasegawa R; Kushiya M; Komuro T; Isaka H
    Eisei Shikenjo Hokoku; 1987; (105):71-3. PubMed ID: 3449175
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between plasma concentrations and cardiac beta-adrenoceptor blockade--a study with oral and intravenous bopindolol.
    Aellig WH; Nüesch E; Engel G; Grevel J; Niederberger W; Rosenthaler J
    Br J Clin Pharmacol; 1986 Jan; 21(1):45-51. PubMed ID: 2868747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac dose-response relationships of oral and intravenous pindolol.
    Carruthers SG
    Br J Clin Pharmacol; 1982; 13(Suppl 2):193S-198S. PubMed ID: 7104142
    [No Abstract]   [Full Text] [Related]  

  • 20. Improvement in wall motion after pindolol: a mechanism for the preservation of left ventricular function in coronary artery disease.
    Manfroi WC; Vieira SR; Koppe VF; Goldin JR; Freitas FM; Faraco EZ; Ribeiro JP
    Braz J Med Biol Res; 1989; 22(7):825-31. PubMed ID: 2698244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.